Stay updated on Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated to v3.6.6 (from v3.6.5). This update appears to be a software version change on the site and does not modify the study details or eligibility information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision label on the page updated from v3.6.4 to v3.6.5, indicating a platform update rather than changes to the study details.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now displays a newer software revision, updating from v3.6.3 to v3.6.4. This reflects an updated build with no visible changes to study content or layout.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.6.3 is now shown on the page, replacing the prior v3.6.2. This indicates a platform version update rather than changes to the study data or content.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of Revision: v3.6.0, indicating a software release; the change represents a platform update rather than new or altered trial data.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded recruitment status and new user guidance sections, and updated the Intervention/Treatment heading and revision version, while removing the older formatting of the heading and the older revision label.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.